Azithromycin
- Generic Name
- Azithromycin
- Brand Names
- Azasite, Zithromax, Zmax
- Drug Type
- Small Molecule
- Chemical Formula
- C38H72N2O12
- CAS Number
- 83905-01-5
- Unique Ingredient Identifier
- J2KLZ20U1M
- Background
Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration . It was initially approved by the FDA in 1991 .
...
- Indication
Azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria in order to prevent the development antimicrobial resistance and maintain the efficacy of azithromycin .
...
- Associated Conditions
- Acute Bacterial Sinusitis (ABS), Acute Otitis Media (AOM), Acute bacterial exacerbation of COPD caused by Haemophilus Influenza Infections, Moraxella Catarrhalis Infection, Streptococcus Pneumoniae Infections, Bacterial Conjunctivitis, Bacterial Sinusitis, Cervicitis, Chancroid, Community Acquired Pneumonia (CAP), Genital Ulcer Disease (GUD), Pelvic Inflammatory Disease (PID), Pharyngitis, Streptococcal Pharyngitis, Tonsillitis bacterial, Tonsillitis streptococcal, Traveler's Diarrhea, Uncomplicated Skin and Skin Structure Infections, Urethritis
- Associated Therapies
- -
Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea
- Conditions
- Interventions
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Bulovka Hospital
- Target Recruit Count
- 161
- Registration Number
- NCT06090565
- Locations
- 🇨🇿
University Hospital Bulovka, Prague, Czechia
🇨🇿Venereology Prague, Medicentrum Beroun, Prague, Czechia
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
- Conditions
- Interventions
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 180
- Registration Number
- NCT06082037
- Locations
- 🇺🇸
Vanderbilt University Medical Center- Site Number : 8400018, Nashville, Tennessee, United States
🇨🇦Investigational Site Number : 1240002, Edmonton, Alberta, Canada
🇨🇳Investigational Site Number : 1560005, Hefei, China
Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy
- Conditions
- Interventions
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Clinical Hospital Colentina
- Target Recruit Count
- 223
- Registration Number
- NCT06077916
- Locations
- 🇷🇴
Colentina Clinical Hospital, Bucuresti, Bucharest, Romania
Azithromycin as Adjunctive Treatment for Uncomplicated Severe Acute Malnutrition
- Conditions
- Interventions
- First Posted Date
- 2023-08-25
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 3000
- Registration Number
- NCT06010719
- Locations
- 🇧🇫
Centre de recherche en Santé de nouna, Nouna, Kossi, Burkina Faso
An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM
- Conditions
- Interventions
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 1266
- Registration Number
- NCT05994742
- Locations
- 🇿🇲
UTH - University Teaching Hospital, Lusaka, Zambia
🇿🇼Chitungwiza Central Hospital, Harare, Zimbabwe
🇿🇼Sally Mugabe Hospital, Harare, Zimbabwe
Rickettsia Clearance Study
- Conditions
- Interventions
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2024-10-11
- Target Recruit Count
- 72
- Registration Number
- NCT05972772
- Locations
- 🇱🇦
Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Vientiane, Vientaine, Lao People's Democratic Republic
Effect Of Azithromycin in Women at Risk of Preterm Labour
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- Beni-Suef University
- Target Recruit Count
- 200
- Registration Number
- NCT05971654
- Locations
- 🇪🇬
Beni-suef university Hospital, Banī Suwayf, Beni Suef, Egypt
A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Participants
- Conditions
- Interventions
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Spero Therapeutics
- Target Recruit Count
- 39
- Registration Number
- NCT05966688
- Locations
- 🇺🇸
Medpace Clinical Pharmacology Unit, Cincinnati, Ohio, United States
Influence of Short-Term Antibiotic Therapy on Exercise
- First Posted Date
- 2023-07-27
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Rutgers, The State University of New Jersey
- Target Recruit Count
- 40
- Registration Number
- NCT05961189
- Locations
- 🇺🇸
Human Performance Clinical Research Lab, Fort Collins, Colorado, United States
🇺🇸Nutrition, and Exercise Metabolism Lab, New Brunswick, New Jersey, United States
Improving Cognition and Gestational Duration With Targeted Nutrition
- Conditions
- Interventions
- Dietary Supplement: M-RUSF+ (Maternal Ready-to-Use Supplementary Food + DHA/EPA/choline)Dietary Supplement: M-RUSF (Maternal Ready-to-Use Supplementary Food)Drug: AzithromycinDrug: AlbendazoleDrug: Sulfadoxine pyrimethamineBehavioral: Cognitive behavioral therapyOther: Insecticide-treated mosquito net
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 1600
- Registration Number
- NCT05949190
- Locations
- 🇸🇱
Blama Massaquoi, Blama Massaquoi, Southern, Sierra Leone
🇸🇱Sahn Malen, Sahn, Southern, Sierra Leone
🇸🇱Zimmi, Zimmi, Southern, Sierra Leone
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.